文献速递认知障碍与痴呆

TDP-43蛋白病与海马硬化的关系及其与APOE ε4单倍型状态的评估:一项社区队列研究

Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study.
PubMed 文献 · Lancet Neurol · 2018-08-06

该研究基于ROS和MAP两个社区老龄与痴呆队列,纳入1044例已故参与者,分析APOE ε4与TDP-43蛋白病及海马硬化的关系。结果显示APOE ε4与更高的TDP-43蛋白病分期(OR 2.0)和负担(0.40)相关,并增加海马硬化风险(OR 2.1),该效应主要由TDP-43负担介导。APOE ε4与临终整体认知较差相关,但额外调整TDP-43负担后该关联减弱。

要点

  • APOE ε4计数与更高的TDP-43蛋白病分期(OR 2.0)和TDP-43负担(0.40)相关。
  • APOE ε4增加海马硬化风险(OR 2.1),该效应主要由TDP-43负担介导而非APOE ε4直接效应。
  • APOE ε4与临终整体认知较差相关,额外调整TDP-43负担后该关联减弱。

核心结论

  • APOE ε4似乎增加TDP-43负担,进而与更高的海马硬化风险相关,海马硬化可能是TDP-43蛋白病的下游病理。
  • TDP-43蛋白病通过独立于阿尔茨海默病病理的机制介导APOE ε4对晚年认知的不良影响,未来研究应考虑TDP-43蛋白病可能是APOE相关神经退行性变的组成部分。

研究设计与样本

  • 研究使用两个社区老龄与痴呆队列——宗教修会研究(ROS)和拉什记忆与老化项目(MAP)的数据。
  • 纳入1044例已故参与者(ROS 470例,MAP 574例),均有APOE基因型和淀粉样β蛋白、配对螺旋丝tau蛋白及TDP-43蛋白病分期的完整病理测量。
  • 最终临床诊断由神经内科医生在死亡后基于所有可用临床数据做出,未参考死后病理。
  • TDP-43蛋白病分期记录为有序变量,TDP-43负担定义为六个脑区半定量六分制评分的平均值。
  • 使用回归模型检验APOE ε4、TDP-43蛋白病与海马硬化的关系,控制性别和死亡年龄,并采用准贝叶斯蒙特卡洛方法进行中介分析。

主要发现

  • APOE ε4计数与更高的TDP-43蛋白病分期相关(OR 2.0,95%CI 1.6–2.6;p=1.9×10⁻⁹)。
  • APOE ε4计数与更高的TDP-43负担相关(0.40,95%CI 0.28–0.52;p=1.2×10⁻¹⁰)。
  • 淀粉样β蛋白、配对螺旋丝tau蛋白或路易体病理不能完全解释上述关联。
  • APOE ε4增加海马硬化风险(OR 2.1,95%CI 1.4–3.0;p=1.7×10⁻⁴);该效应主要由TDP-43负担介导(中介效应p<1.0×10⁻⁴),而非APOE ε4直接效应(直接效应p=0.40)。
  • 在调整淀粉样β蛋白和配对螺旋丝tau蛋白后,APOE ε4与临终整体认知较差相关(估计效应−0.18,95%CI −0.31至−0.04;p=0.010),但额外调整TDP-43负担后该关联减弱(−0.09,95%CI −0.22至0.04;p=0.18)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transactive response DNA-binding protein of 43 kDa (TDP-43) proteinopathy in older adults frequently coexists with Alzheimer's disease pathology and hippocampal sclerosis. It is unclear whether there is a link between APOE ε4 and TDP-43 proteinopathy, and the role of APOE ε4 in the association of TDP-43 proteinopathy with hippocampal sclerosis remains to be examined. We investigated the relationships of TDP-43 proteinopathy and hippocampal sclerosis with APOE ε4. METHODS: We used data from two community-based cohort studies of ageing and dementia: the Religious Orders Study (ROS) and the Rush Memory and Aging Project (MAP). A battery of cognitive tests examining multiple cognitive domains is given to ROS-MAP participants each year, and a measure of annual global cognitive function for each participant is derived by averaging Z scores of these tests. The final clinical diagnosis is assigned after death by a neurologist using all available clinical data without access to post-mortem pathology. Amyloid-β, paired helical filament tau, Lewy bodies, TDP-43, and hippocampal sclerosis were microscopically evaluated in the midbrain, medial temporal, and neocortical regions that capture the progression of each neuropathology. TDP-43 proteinopathy topographic stage was recorded as an ordinal variable, and TDP-43 burden was defined by averaging a semi-quantitative six-point scale across six brain regions. The relationships among APOE ε4, TDP-43 proteinopathy, and hippocampal sclerosis were tested with regression models controlled for sex and age at death, and they were further explored with a mediation analysis using the quasi-Bayesian Monte Carlo method. FINDINGS: ROS began data collection in 1994, and MAP began data collection in 1997. The data included in this study were analysed from Jan 16, 2017, to July 12, 2017. When analysis began in January, 2017, a total of 1059 ROS-MAP participants who were deceased had APOE genotype and complete pathological measures for amyloid-β, paired helical filament tau, and TDP-43 proteinopathy stage. After excluding 15 participants with other pathological diagnoses, 1044 participants, 1042 of whom also had measures of Lewy body pathology, were included in this study (470 from ROS and 574 from MAP). APOE ε4 count was associated with higher TDP-43 proteinopathy stage (odds ratio [OR] 2·0, 95% CI 1·6-2·6; p=1·9 × 10-9) and TDP-43 burden (0·40, 0·28-0·52; p=1·2 × 10-10). Amyloid-β, paired helical filament tau, or Lewy body pathology did not fully explain this association. APOE ε4 increased the odds of hippocampal sclerosis (OR 2·1, 95% CI 1·4-3·0; p=1·7 × 10-4); this effect was largely mediated by TDP-43 burden (mediated effect p<1·0 × 10-4) but not directly by APOE ε4 (direct effect p=0·40). APOE ε4 was associated with worse global cognition proximate to death even after adjusting for amyloid-β and paired helical filament tau (estimated effect -0·18, 95% CI -0·31 to -0·04; p=0·010), but this association was attenuated by additionally adjusting for TDP-43 burden (-0·09, -0·22 to 0·04; p=0·18). INTERPRETATION: APOE ε4 seems to increase TDP-43 burden, and this effect in turn was associated with higher odds of hippocampal sclerosis, a pathology potentially downstream of TDP-43 proteinopathy. TDP-43 proteinopathy contributes to the detrimental effect of APOE ε4 on late-life cognition through mechanisms independent of Alzheimer's disease pathology, and future research should consider that TDP-43 proteinopathy might be an integral component of APOE-related neurodegeneration. FUNDING: US National Institute on Aging and Alzheimer's Association.

来源:Lancet Neurol,查看原文。版权归原作者所有。

引用

  1. Yang HS, Yu L, White CC, et al. Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study. Lancet Neurol. 2018. PMID: 30093249. doi:10.1016/S1474-4422(18)30251-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。